Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Salarius Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 20.5K | Feb 20, 2024 | Direct | ||
OMEROS CORP | Director | Stock Option (Right to Buy) | 15K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OMER | OMEROS CORP | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Feb 20, 2024 | 1 | $0 | 4 | Feb 22, 2024 | Director |
OMER | OMEROS CORP | Jun 23, 2023 | 1 | $0 | 4 | Jun 27, 2023 | Director |
OMER | OMEROS CORP | May 22, 2023 | 3 | -$5.8K | 4 | May 23, 2023 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
OMER | OMEROS CORP | Sep 21, 2022 | 1 | $0 | 4 | Sep 23, 2022 | Director |
OMER | OMEROS CORP | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Jun 3, 2022 | 1 | $5.15K | 4 | Jun 6, 2022 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Jan 20, 2022 | 1 | $0 | 4 | Jan 21, 2022 | Director |
OMER | OMEROS CORP | Sep 8, 2021 | 2 | $94.4K | 4 | Sep 9, 2021 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Aug 10, 2021 | 1 | $6.17K | 4 | Aug 11, 2021 | Director |
OMER | OMEROS CORP | Jun 11, 2021 | 1 | $0 | 4 | Feb 14, 2022 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Aug 21, 2020 | 1 | $3.92K | 4/A | Jun 6, 2022 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Feb 11, 2020 | 1 | $5K | 4/A | Jun 6, 2022 | Director |
SLRX | Salarius Pharmaceuticals, Inc. | Nov 25, 2019 | 1 | $10.8K | 4/A | Jun 6, 2022 | Director |